Company

Endotronix

Rocket Ship Rating

Rocket Ship Rating: 92 out of 100

Advancing the Treatment of Heart Failure. Together.

Also known as Endotronix, Inc.

Care delivery & digital health
Medical devices & diagnostics
Hardware

Status: Acquiredas of 2026-09-17Source (opens in a new tab)
Business model: B2B
Headquarters: Naperville, Illinois, United States
Customers: patients with NYHA class III heart failure, caregivers, and clinicians
Legal name: Endotronix, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Empowering proactive heart failure management in the home

Funding snapshot

Total raised: $116MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $69.3M2018-09-14

Funding rounds

Round, 2018: $69.3M2018-09-14, SEC form D sold, 38 investors
Round, 2016: $37.1M2016-07-05, SEC form D sold, 52 investors
Round, 2015: $3M2015-06-18, SEC form D sold, 25 investors
Round, 2014: $2.2M2014-07-07, SEC form D sold, 10 investors
Round, 2014: $1.6M2014-03-25, SEC form D sold, 4 investors
Round, 2013: $1.2M2013-01-31, SEC form D sold, 13 investors
Round, 2011: $1.8M2011-07-25, SEC form D sold, 14 investors

About the company

Status notes: Edwards Lifesciences acquires Endotronix

Products

Hardware: Cordella PA Sensor and HF System

Exit

Acquisition: 2024-08